| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JCONREL.2004.12.018 |
| P698 | PubMed publication ID | 15763623 |
| P2093 | author name string | You Han Bae | |
| Kun Na | |||
| Eun Seong Lee | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| micelles | Q421110 | ||
| P304 | page(s) | 405-418 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. | |
| P478 | volume | 103 |
| Q39653765 | A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro |
| Q36327549 | A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting |
| Q57367146 | A pH-sensitive polymeric nanovesicle based on biodegradable poly(ethylene glycol)-b-poly(2-(diisopropylamino)ethyl aspartate) as a MRI-visible drug delivery system |
| Q38754657 | A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules |
| Q24610184 | A virus-mimetic nanogel vehicle |
| Q37234202 | Advances of cancer therapy by nanotechnology |
| Q38026625 | Analysis on the current status of targeted drug delivery to tumors |
| Q37031597 | Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review |
| Q38090650 | Anthracyclines as effective anticancer drugs |
| Q36871795 | Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles. |
| Q33752783 | Antigen delivery with poly(propylacrylic acid) conjugation enhances MHC-1 presentation and T-cell activation |
| Q60308668 | Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro |
| Q40568410 | Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading. |
| Q38731667 | Biodegradable Stimuli-Responsive Polymeric Micelles for Treatment of Malignancy. |
| Q35686920 | Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies |
| Q37955451 | Cancer nanomedicines targeting tumor extracellular pH. |
| Q28538811 | Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles |
| Q34030709 | Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects |
| Q28468315 | Chemophototherapy: An Emerging Treatment Option for Solid Tumors |
| Q37178507 | Chemotherapy drug delivery from calcium phosphate nanoparticles |
| Q49743645 | Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer. |
| Q45362938 | Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery |
| Q37765187 | Clinical developments in nanotechnology for cancer therapy |
| Q50895514 | Co-delivery of doxorubicin and arsenite with reduction and pH dual-sensitive vesicle for synergistic cancer therapy. |
| Q39011686 | Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy. |
| Q34823319 | Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. |
| Q35013627 | Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms. |
| Q37383847 | Cryopreservable and tumorigenic three-dimensional tumor culture in porous poly(lactic-co-glycolic acid) microsphere |
| Q30362001 | Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment. |
| Q38787316 | Development of Long-Circulating pH-Sensitive Liposomes to Circumvent Gemcitabine Resistance in Pancreatic Cancer Cells |
| Q40242581 | Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid |
| Q26749611 | Development of polymeric micelles for targeting intractable cancers |
| Q50752147 | Development of shell cross-linked nanoparticles based on boronic acid-related reactions for self-regulated insulin delivery. |
| Q37265495 | Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery |
| Q57436538 | Dodging Drug-Resistant Cancer with Diamonds |
| Q51907228 | Doxorubicin and beta-lapachone release and interaction with micellar core materials: experiment and modeling. |
| Q30472420 | Doxorubicin as a Molecular Nanotheranostic Agent: Effect of Doxorubicin Encapsulation in Micelles or Nanoemulsions on the Ultrasound-Mediated Intracellular Delivery and Nuclear Trafficking |
| Q39600924 | Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro |
| Q35025106 | Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice |
| Q36920351 | Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. |
| Q40090156 | Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation |
| Q59135212 | Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer |
| Q36316921 | Drug delivery strategies for cathepsin inhibitors in joint diseases |
| Q38608253 | Drug-conjugated polymers as gene carriers for synergistic therapeutic effect. |
| Q92728866 | Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy |
| Q35918831 | Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor |
| Q36176104 | Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles |
| Q39214141 | Endothelial cell calpain as a critical modulator of angiogenesis |
| Q28073956 | Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective. |
| Q37314701 | Engineered polymers for advanced drug delivery |
| Q38085594 | Engineering multifunctional nanoparticles: all-in-one versus one-for-all. |
| Q33882801 | Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer |
| Q40154265 | Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells |
| Q35558002 | Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug |
| Q33861943 | Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model |
| Q26828930 | Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities |
| Q57728948 | Extracellular pH-Activated Nanocarriers for Enhanced Drug Delivery to Tumors |
| Q28486235 | Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor |
| Q39227123 | Fabrication of novel coumarin derivative functionalized polypseudorotaxane micelles for drug delivery |
| Q47156644 | Fabrication of pH-responsive PLGA(UCNPs/DOX) nanocapsules with upconversion luminescence for drug delivery. |
| Q39115464 | Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle. |
| Q49154861 | Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity |
| Q37776257 | Folate-Targeted Therapies for Cancer |
| Q39352164 | Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery |
| Q39629193 | Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery |
| Q35550112 | Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance |
| Q35694291 | Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles |
| Q36769984 | Functionalized micellar systems for cancer targeted drug delivery |
| Q55688327 | Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy. |
| Q35609161 | IT-141, a Polymer Micelle Encapsulating SN-38, Induces Tumor Regression in Multiple Colorectal Cancer Models |
| Q46570011 | In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy |
| Q37383842 | In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer |
| Q92212578 | Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer |
| Q39652008 | Intracellular pH‐Responsive Mesoporous Silica Nanoparticles for the Controlled Release of Anticancer Chemotherapeutics |
| Q36128722 | Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes |
| Q35024848 | L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity. |
| Q42252410 | Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications |
| Q39629460 | Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells |
| Q51007292 | Liposomes assembled from a dual drug-tailed phospholipid for cancer therapy. |
| Q92145740 | Loading and Releasing Ciprofloxacin in Photoactivatable Liposomes |
| Q37066021 | Mannose 6-phosphate receptor targeting and its applications in human diseases |
| Q49959001 | Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance. |
| Q36655007 | Micellar nanocarriers: pharmaceutical perspectives |
| Q39444049 | Monitoring pH-triggered drug release from radioluminescent nanocapsules with X-ray excited optical luminescence |
| Q36980340 | Multi-functional nanocarriers to overcome tumor drug resistance |
| Q53698268 | Multidrug Resistance in Cancer Circumvented Using a Cytosolic Drug Reservoir. |
| Q53061279 | Multifunctional Rbx WO3 nanorods for simultaneous combined chemo-photothermal therapy and photoacoustic/CT imaging. |
| Q37344163 | Multifunctional micellar nanomedicine for cancer therapy |
| Q39017324 | Multifunctional nanoassemblies of block copolymers for future cancer therapy |
| Q38383487 | Multifunctional nanomedicines: potentials and prospects |
| Q38119471 | Multifunctional nanomicellar systems for delivering anticancer drugs. |
| Q29616699 | Nanocarriers as an emerging platform for cancer therapy |
| Q37508725 | Nanocarriers' entry into the cell: relevance to drug delivery |
| Q38234908 | Nanodrug delivery in reversing multidrug resistance in cancer cells |
| Q33689872 | Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect |
| Q38422748 | Nanoparticle approaches to combating drug resistance |
| Q38813380 | Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer |
| Q29615628 | Nanoparticle therapeutics: an emerging treatment modality for cancer |
| Q36031889 | Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma |
| Q38131264 | Nanopreparations to overcome multidrug resistance in cancer |
| Q39022735 | Nanostructural systems developed with positive charge generation to drug delivery |
| Q38177370 | Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles |
| Q39164157 | Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier |
| Q39663001 | Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy |
| Q37362252 | Peptide-based Biopolymers in Biomedicine and Biotechnology |
| Q38067306 | Perspectives and potential applications of nanomedicine in breast and prostate cancer |
| Q30403731 | Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors |
| Q36105465 | Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. |
| Q30483587 | Physicochemical aspects of doxorubicin-loaded pH-sensitive polymeric micelle formulations from a mixture of poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) [corrected] |
| Q38248809 | Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles |
| Q44589411 | Poly(acrylic acid) modified lanthanide-doped GdVO4 hollow spheres for up-conversion cell imaging, MRI and pH-dependent drug release |
| Q42033682 | Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations |
| Q38943134 | Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy. |
| Q30441883 | Polymer-coated echogenic lipid nanoparticles with dual release triggers. |
| Q38588547 | Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs. |
| Q36349714 | Polymeric micelles for drug delivery |
| Q36985038 | Polymeric micelles for drug targeting |
| Q30478123 | Polymeric micelles in anticancer therapy: targeting, imaging and triggered release |
| Q36225509 | Polymers for drug delivery systems |
| Q24540353 | Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs. |
| Q30391504 | Potential for layered double hydroxides-based, innovative drug delivery systems |
| Q33414140 | Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies |
| Q64882438 | QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation. |
| Q41489085 | Quantitative analysis and comparison of 3D morphology between viable and apoptotic MCF-7 breast cancer cells and characterization of nuclear fragmentation. |
| Q35692091 | RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells |
| Q36001035 | Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids |
| Q46938274 | Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries |
| Q58735813 | Recent advances in "smart" delivery systems for extended drug release in cancer therapy |
| Q38204933 | Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy |
| Q37197375 | Recent progress in tumor pH targeting nanotechnology |
| Q37987369 | Reservoir-based polymer drug delivery systems |
| Q37380142 | Review: doxorubicin delivery systems based on chitosan for cancer therapy. |
| Q38964080 | Role of polymeric endosomolytic agents in gene transfection: a comparative study of poly(L-lysine) grafted with monomeric L-histidine analogue and poly(L-histidine). |
| Q33821120 | SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer |
| Q37580416 | SUMOylation of PES1 upregulates its stability and function via inhibiting its ubiquitination |
| Q47098115 | Self-Assembled Hydrogel Nanoparticles for Drug Delivery Applications. |
| Q37576006 | Self-Assembly Assisted Fabrication of Dextran-Based Nanohydrogels with Reduction-Cleavable Junctions for Applications as Efficient Drug Delivery Systems. |
| Q47691641 | Self-Assembly of an Amphiphilic Janus Camptothecin-Floxuridine Conjugate into Liposome-Like Nanocapsules for More Efficacious Combination Chemotherapy in Cancer |
| Q33385557 | Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery |
| Q35126960 | Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance |
| Q35088244 | Stimuli-responsive nanomaterials for therapeutic protein delivery |
| Q36307519 | Stimuli-responsive nanoparticles for targeting the tumor microenvironment. |
| Q38062891 | Stimuli-sensitive synthetic polypeptide-based materials for drug and gene delivery |
| Q37775972 | Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. |
| Q37575475 | Stimulus-responsive targeted nanomicelles for effective cancer therapy |
| Q38062884 | Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers. |
| Q37016869 | Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance |
| Q36308723 | Supramolecular nanoparticles generated by the self-assembly of polyrotaxanes for antitumor drug delivery |
| Q37641692 | Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer |
| Q35575232 | Synthesis of polysaccharide-block-polypeptide copolymer for potential co-delivery of drug and plasmid DNA. |
| Q36709245 | Targeted delivery of doxorubicin through conjugation with EGF receptor-binding peptide overcomes drug resistance in human colon cancer cells |
| Q36871933 | Targeted pharmaceutical nanocarriers for cancer therapy and imaging |
| Q36934007 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation |
| Q36680180 | Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance |
| Q33792538 | Temperature triggered self-assembly of polypeptides into multivalent spherical micelles |
| Q37304764 | The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer |
| Q37403035 | The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system |
| Q35202143 | Thermal and pH Sensitive Multifunctional Polymer Nanoparticles for Cancer Imaging and Therapy |
| Q43080810 | Thermosensitive micelles from PEG-based ether-anhydride triblock copolymers |
| Q37638763 | Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer |
| Q36326953 | Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution |
| Q37238828 | Tumor cells upregulate normoxic HIF-1α in response to doxorubicin |
| Q40083242 | Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine). |
| Q53362272 | Two-shell structured PMAA@CeO2 nanocontainers loaded with 2-mercaptobenzothiazole for corrosion protection of damaged epoxy coated AA 2024-T3. |
| Q30490995 | Ultrasonic-activated micellar drug delivery for cancer treatment |
| Q38012539 | Ultrasound-mediated micellar drug delivery |
| Q39351089 | Updates on smart polymeric carrier systems for protein delivery. |
| Q51472334 | Visible Light and pH Responsive Polymer-Coated Mesoporous Silica Nanohybrids for Controlled Release. |
| Q35934993 | pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells |
| Q36223337 | pH-Sensitive polymeric micelle-based pH probe for detecting and imaging acidic biological environments |
| Q38950131 | pH-responsive nano carriers for doxorubicin delivery |
| Q52587140 | pH-responsive polymeric micelles self-assembled from amphiphilic copolymer modified with lipid used as doxorubicin delivery carriers. |
| Q41483792 | pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity |
| Q38205583 | pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances |
Search more.